The Italy Combined ABO and Rhesus Typing Market is poised for steady growth through 2026, driven by rising healthcare demands. Explore IndexBox’s latest report for in-depth insights and detailed forecasts that stretch all the way to 2035
Browsing: Diagnostic Testing
ClearNote Health is thrilled to announce that it has secured In Vitro Diagnostic approval in the UK for its revolutionary Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test-marking a powerful breakthrough in the battle for early cancer detection